Stock Events

Oncopeptides AB 

$0.27
5
+$0+0% Monday 20:00

Statistics

Day High
0.27
Day Low
0.27
52W High
0.85
52W Low
0.27
Volume
200
Avg. Volume
3
Mkt Cap
55.92M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

8NovConfirmed
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-10.33
-6.99
-3.66
-0.32
Expected EPS
-0.72
Actual EPS
-1

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ONPPF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Oncopeptides AB (publ), a biotech company, develops pharmaceuticals drugs for the treatment of cancer in the United States, Europe, and internationally. Its lead product candidate is melflufen, an anti-cancer peptide drug conjugate for the treatment of relapsed refractory multiple myeloma in adult patients. Oncopeptides AB (publ) was incorporated in 2000 and is headquartered in Stockholm, Sweden.
Show more...
CEO
Jakob Lindberg
Employees
62
Country
SE
ISIN
SE0009414576
WKN
000A2DLU2

Listings